Companies · Other Health Care

COTA, Inc.

NEW YORK · Other Health Care

Diligence memoA one-page analyst read on COTA, Inc. — recommendation, valuation, rhythm, risks.
$43.8M
Total raised · real
2
Rounds
10.6×
Latest step-up
Top 10%
Sector rank · raised
Series B
Latest stage · inferred · Thu Feb 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

COTA, Inc. looks over-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Over-valued
  • Modeled value is 1.98× the median modeled value of Series B Other Health Care companies in 2016–2018 (74 peers) — value vs value, same stage and era.
Dormant
  • Last raise 8.4 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

COTA, Inc. is one of 5377 Other Health Care companies tracked from NEW YORK. By capital raised it ranks among the largest (ahead of 91% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
$5M–$25M
Issuer revenue
Rule 506(b)
Reg D exemption
7
Investors (latest)
2018-02-01
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$250M$500M$750M$1.0BSeed · 2014-09-02 Raised $3.8M (real) Modeled valuation $93M (est)$3.8M$93MSeed2014Series B · 2018-02-01 Raised $40M (real) Modeled valuation $886M (est)$40M$886MSeries B2018+$40MCumulative $44M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$3.8M · 2014
Series B$40.0M · 2018no Series A on file

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Series A — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 50%.

Modeled valuation trajectory
$886.2M
Base estimate est.
$94.0M
Conservative case
$3.4B
Upside case
$222.2M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ba $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Seed · modeled $93.3M · 2014-09-022014Series B · modeled $886.2M · 2018-02-012018
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
64%
Survival probability
42% low · 78% high
1.36×/yr
Annual markup
1.64×/yr upside case
6.0 yr
Elapsed time used
8.4 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
41 mo
Avg between rounds
$12.8M/yr
Capital velocity
11.8 yr
On record since
2014
First round
2
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 18× above median
This company$43.8M
Sector median$2.4M
Latest round — vs other Series B rounds in sector (real $, this stage) 2.2× above median
This company$40.0M
Sector median$17.8M
Modeled value — vs sector median (estimate, all stages) 40× above median
This company$886.2M
Sector median$22.1M

Raised more than 91% of sector peers (real $). Modeled value above 96% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #2 of 74.

This companyCohort peer
$100.0M$1.0B$10.0M$100.0M$1.0BCapital raised (log)Podicare Services, Inc. · Series B Raised $40.0M · modeled $886.2M (est)Fresenius Medical Care - Meridian Health System, LLC · Series B Raised $39.0M · modeled $863.9M (est)Headspace, Inc. · Series B Raised $115.9M · modeled $860.6M (est)Spine Holdings LLC · Series B Raised $38.4M · modeled $851.6M (est)Chrono Therapeutics Inc. · Series B Raised $51.4M · modeled $833.2M (est)MedCPU, Inc. · Series B Raised $36.6M · modeled $776.2M (est)Capital Funding Bancorp, Inc. · Series B Raised $35.0M · modeled $775.4M (est)Phreesia, Inc. · Series B Raised $83.8M · modeled $753.2M (est)Labconnect Holdings, Inc. · Series B Raised $33.4M · modeled $739.0M (est)Zoonie, LLC · Series B Raised $52.0M · modeled $708.1M (est)Sotera Wireless, Inc. · Series B Raised $98.5M · modeled $705.3M (est)COTA, Inc. (this company) Raised $43.8M · modeled $886.2M (est)COTA, Inc.
CompanyStageRaised · realValue · estvs peer med.
Podicare Services, Inc.Series B$40.0M$886.2M1.98×
COTA, Inc. this companySeries B$43.8M$886.2M1.98×
Fresenius Medical Care - Meridian Health System, LLCSeries B$39.0M$863.9M1.93×
Headspace, Inc.Series B$115.9M$860.6M1.92×
Spine Holdings LLCSeries B$38.4M$851.6M1.90×
Chrono Therapeutics Inc.Series B$51.4M$833.2M1.86×
MedCPU, Inc.Series B$36.6M$776.2M1.73×
Capital Funding Bancorp, Inc.Series B$35.0M$775.4M1.73×
Phreesia, Inc.Series B$83.8M$753.2M1.68×
Labconnect Holdings, Inc.Series B$33.4M$739.0M1.65×
Zoonie, LLCSeries B$52.0M$708.1M1.58×
Sotera Wireless, Inc.Series B$98.5M$705.3M1.58×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$3.8M2014-09-02$18.8M$93.3M85%
Series B$40.0M2018-02-01$222.2M$886.2M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$3.8M2014-09-02
    • First recorded raise — entered as Seed.
    • 3 investors on this round.
  2. Series B$40.0M2018-02-01
    • Raised again after 41 mo — slower than the ~14 mo sector norm.
    • Round 10.6× larger than the prior — scaling up.
    • 7 investors on this round.
Intelligence
2021 ~Q3
Modeled next raise · ~41mo cadence
$120.0M
Modeled next size est.range $78.0M$192.0M
10.6×
Last step-up
$12.8M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Andrew Pecora3 other2018-02
Eric Schultz3 other2018-02
Andrew L. Pecora2 other2014-09
Andrew Von Eschenbach2 other2018-02
Donald Berwick2 other2018-02
David L. Siegel1 other2014-09
Thomas Gallucci1 other2018-02
Allen Karp2018-02
Andre Goy2018-02
Andre T. Goy2014-09
Andrew Norden2018-02
Dana Callow2018-02
David M. McCabe2014-09
Edward T. Licitra2014-09
Elizabeth Rushforth2018-02
Glenn T. Pomerantz2014-09
John Hervey2018-02
John T. Crowley2014-09
John T. Hervey2014-09
Joseph Davi2018-02
Joseph T. Davi2014-09
Kelly T. Choi2014-09
Kevin Casey Simon2014-09
Minal T. Patel2014-09
Registry & provenance

COTA, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1620729
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Zarbee's, IncOther Health CareSeries B$43.8M$375.5Msame sector · same stage
Pivot Medical IncOther Health CareSeries B$43.1M$717.7Msame sector · same stage
Candesant Biomedical, Inc.Other Health CareSeries B$44.5M$455.3Msame sector · same stage
Diality IncOther Health CareSeries B$42.9M$337.7Msame sector · same stage
PatientPing, Inc.Other Health CareSeries B$41.4M$701.2Msame sector · same stage
Brighter Inc.Other Health CareSeries B$41.1M$576.0Msame sector · same stage
Trainer Rx, Inc.Other Health CareSeries B$47.0M$405.5Msame sector · same stage
Solta Medical IncOther Health CareSeries B$47.5M$564.9Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Galena Innovations, Inc.Other Health CarePre-Seed$1.2M86%
Leaa (Us), Inc.Other Health CareSeries A$196.5M85%
HC Jones, Inc.Other Health CareSeries A$33.4M85%
CBD FLA Inc.Other Health CarePre-Seed$9.2M84%
Ancora Heart, Inc.Other Health CareSeries C$1.4B84%
SCA-Bonita Springs, LLCOther Health CarePre-Seed$1.8M84%
Cardia, Inc.Other Health CareSeed$9.0M83%
Cartiva, Inc.Other Health CareSeries A$141.3M83%
Frequently asked
How much funding has COTA, Inc. raised?
COTA, Inc. has raised approximately $43.8M in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is COTA, Inc.'s estimated valuation?
Provath's modeled valuation for COTA, Inc. is approximately $886.2M (modeled range $94.0M–$3.4B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is COTA, Inc. at?
COTA, Inc.'s latest modeled financing stage is Series B. Its most recent recorded round closed around Thu Feb 01.
What does COTA, Inc. do and where is it based?
COTA, Inc. operates in the Other Health Care sector, based in NEW YORK.
Explore related

See where COTA, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at COTA, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.